Hemady™ (dexamethasone) – New orphan drug approval
October 3, 2019 - The FDA approved Dexcel Pharma’s Hemady (dexamethasone) 20 mg tablets, in combination with other antimyeloma products for the treatment of adults with multiple myeloma.
Download PDF
